Furthermore, there was 3.13 times increased MS risk in association with the haplotype MMP-9 T, MMP-7 G, and MMP-2 C (TGC) in comparison to the CAG haplotype [28]. This evidence concerns the gene MMP2 and myeloid sarcoma.